— Know what they know.
Not Investment Advice

REPL NASDAQ

Replimune Group, Inc.
1W: +5.7% 1M: -18.2% 3M: +13.9% YTD: +46.9% 1Y: +210.4% 3Y: -21.3% 5Y: -59.5%
$13.07
-0.38 (-2.83%)
 
Weekly Expected Move ±6.5%
$11 $12 $13 $14 $15
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $1.1B mcap · 79M float · 5.95% daily turnover · Short 56% of daily vol

Balance Sheet Trends

Total Assets
$332M -39.7% ▼
5Y CAGR: -9.4%
Total Liabilities
$166M +22.7% ▲
5Y CAGR: +30.2%
Shareholders Equity
$166M -60.0% ▼
5Y CAGR: -19.7%
Cash & Investments
$269M -44.4% ▼
5Y CAGR: -10.8%
Total Debt
$112M +46.5% ▲
5Y CAGR: +27.4%
Net Debt
-$97M -178.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$106M$147M$74M$111M$209M
Short-Term Investments$290M$437M$346M$373M$60M
Cash & ST Investments$396M$583M$421M$484M$269M
Net Receivables$3M$3M$5M$4M$2M
Inventory$0$0$0$0$0
Other Current Assets$0$6M$8M$0$9M
Total Current Assets$404M$593M$434M$496M$279M
Property, Plant & Equip.$56M$52M$52M$53M$49M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$2M$2M$2M$3M$5M
Total Non-Current Assets$57M$54M$54M$55M$53M
Total Assets$461M$647M$488M$551M$332M
— Liabilities —
Accounts Payable$4M$5M$3M$12M$7M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$7M$13M$17M$6M$20M
Total Current Liabilities$21M$34M$40M$62M$58M
Long-Term Debt$0$29M$45M$46M$83M
Other Non-Current Liab.$0$472K$786K$941K$455K
Total Non-Current Liabilities$29M$57M$73M$73M$108M
Total Liabilities$50M$91M$113M$135M$166M
— Equity —
Common Stock$47K$57K$61K$77K$82K
Retained Earnings-$311M-$485M-$701M-$949M-$1.3B
Accumulated OCI-$973K$6M$5M$5M$5M
Total Stockholders Equity$411M$555M$375M$416M$166M
Total Liabilities & Equity$461M$647M$488M$551M$332M
— Key Metrics —
Total Debt$33M$61M$76M$76M$112M
Net Debt-$73M-$86M$1M-$35M-$97M
Total Investments$290M$437M$346M$373M$60M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms